The year began with a clear and deliberate focus on prevention, as Sankalp India Foundation formalised a landmark tripartite Memorandum of Understanding with Indian Oil Corporation Limited and the National Health Mission, Madhya Pradesh, on 5 January 2026. This collaboration marks a significant step forward in strengthening antenatal screening and prevention of thalassemia and sickle cell disease across the state.
Under this partnership, antenatal screening services will be supported across 25 districts of Madhya Pradesh, with a target of 12,000 screenings. The objective is simple and urgent: to prevent the birth of children affected by genetic blood disorders by identifying risk early in pregnancy and enabling timely counselling and intervention. For communities that often have limited access to specialised healthcare, prevention is not just cost-effective, it is life-altering.
The programme moved swiftly from commitment to action. Within weeks of signing the MoU, 16 centres became operational, and over 200 screenings were already completed. Services have reached rural, tribal, and underprivileged populations, ensuring that prevention efforts are not confined to urban centres but extend to those who need them most.
This initiative reinforces a core belief that guides Sankalp’s work: while management and cure remain essential, lasting change begins with prevention. Each screening represents a family empowered with knowledge, a future safeguarded, and a step closer to reducing the burden of hemoglobinopathies at the source.
Sankalp India Foundation expresses deep gratitude to the CSR leadership of Indian Oil Corporation Limited and the National Health Mission, Madhya Pradesh, for their trust and partnership. Together, this collaboration is translating public health intent into real impact, preventing affected births and strengthening healthier futures, one screening at a time.